Deep neural networks incorporating segmentation provide highly accurate classification of immunofluorescence patterns on the tissue substrates esophagus and salt-split skin for detection of autoimmune bullous dermatoses (AIBD). A recently published study in collaboration with researchers at the Department of Dermatology and Lübeck Institute of Experimental Dermatology of the University of Lübeck, Germany describes the development […]

Microscopy is a fundamental tool in biomedical research and clinical diagnostics. However, each laboratory has different requirements for its instruments: While laboratories with a low sample throughput tend to use manual microscopes, for example for the evaluation of indirect immunofluorescence tests, large laboratories with a high throughput and a broad diagnostic spectrum rather benefit from

EUROIMMUN ELISAs based on recombinant antigens p52 (IgM) and glycoprotein B (IgG) from cytomegalovirus (CMV) provided a higher rate of conclusive results in first-line testing of samples from pregnant women than lysate-based assays. A recombinant testing strategy could thus help to reduce the number of analyses required for routine CMV screening during pregnancy. These are

EUROIMMUN ELISAs for detection of antibodies against Crimean-Congo haemorrhagic fever virus (CCHFV) reliably identify acute CCHF cases and are suitable for laboratories involved in on-site outbreak support. This was demonstrated in a recently published study in collaboration with scientists at a national reference laboratory in Turkey. Crimean-Congo haemorrhagic fever (CCHF) is a life-threatening tick-borne disease

Indirect immunofluorescence diagnostics is one of EUROIMMUN’s long-standing areas of expertise, at least since the introduction of the then ground-breaking BIOCHIP technology in 1983. In the development of new test systems and automation solutions we focus on the current needs of diagnostic laboratories of all sample throughputs. We aim to enable laboratories to process our